Cargando…
1164P Patient-reported outcomes in patients with advanced NSCLC before and during the COVID-19 pandemic in the German prospective CRISP Registry real-world cohort (AIO-TRK-0315)
Autores principales: | Sebastian, M., Griesinger, F., von der Heyde, E., Dörfel, S., Wiegand, J.H., Schiefer, C., Losem, C., Jänicke, M., Fleitz, A., Zacharias, S., Hipper, A., Dietel, C., Bleckmann, A., Benkelmann, R., Boesche, M., Grah, C., Müller, A., Eberhardt, W.E.E., Thomas, M. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
European Society for Medical Oncology. Published by Elsevier Ltd.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9472486/ http://dx.doi.org/10.1016/j.annonc.2022.07.1287 |
Ejemplares similares
-
Prognostic factors in nonsmall cell lung cancer: insights from the German CRISP registry
por: Metzenmacher, Martin, et al.
Publicado: (2023) -
Aios in coronatijd
por: Maria Greijn, Claudia, et al.
Publicado: (2020) -
Clinical benefit and cost-effectiveness analysis of liquid biopsy application in patients with advanced non-small cell lung cancer (NSCLC): a modelling approach
por: Englmeier, Fabienne, et al.
Publicado: (2022) -
Nal-IRI with 5-fluorouracil (5-FU) and leucovorin or gemcitabine plus cisplatin in advanced biliary tract cancer - the NIFE trial (AIO-YMO HEP-0315) an open label, non-comparative, randomized, multicenter phase II study
por: Perkhofer, L., et al.
Publicado: (2019) -
P03.15. Developing a Health Qigong program for children: a 16-week curriculum
por: Wang, C, et al.
Publicado: (2012)